Acute Myeloblastic Leukemia with Maturation

Search Trials
Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer
Status:
Completed
Last Changed:
Jun 24, 2013
First Changed:
Aug 29, 2003
Disease(s):
Leukemia
Intervention(s):
azacitidinesodium phenylbutyrate
Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
Status:
Completed
Last Changed:
Jun 26, 2015
First Changed:
Jan 27, 2003
Disease(s):
Leukemia
Intervention(s):
filgrastimsargramostimcytarabinedaunorubicin hydrochloridezosuquidar trihydrochloridePlacebo
Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
Status:
Completed
Last Changed:
Jun 26, 2015
First Changed:
Jan 27, 2003
Disease(s):
Leukemia
Intervention(s):
filgrastimsargramostimcytarabinedaunorubicin hydrochloridezosuquidar trihydrochloridePlacebo
Quality of Life Model for Older Patients With AML
Status:
Recruiting
Last Changed:
Dec 27, 2021
First Changed:
May 8, 2020
Disease(s):
AML, Adult
S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin
Status:
Completed
Last Changed:
Mar 6, 2015
First Changed:
Jan 4, 2012
Disease(s):
Leukemia
Intervention(s):
DNA analysisRNA analysisgene expression analysismutation analysispolymerase chain reactionlaboratory biomarker analysis

Connect. Empower. Inspire.